Manmohan Singh, Ph.D.
About Manmohan Singh, Ph.D.
Manmohan Singh, Ph.D., is the Chief Technology Officer with extensive experience in drug discovery and development, having worked at Takeda Pharmaceuticals, Novartis, and Chiron Corporation. He is recognized for his expertise in vaccine adjuvants and delivery systems.
Chief Technology Officer
Manmohan Singh, Ph.D., currently holds the position of Chief Technology Officer. With extensive experience in the pharmaceutical industry, he brings over 24 years of drug discovery and development experience from various renowned organizations, including Takeda Pharmaceuticals, Novartis, and Chiron Corporation. His role bridges advanced technology and strategic oversight to drive innovation in his field.
Education and Expertise
Manmohan Singh earned his Ph.D. in Pharmaceutics and Drug Delivery from the National Institute of Immunology in New Delhi, India. He is recognized as one of the leading experts in the fields of adjuvants and vaccine delivery systems. His expertise is further evidenced by more than 120 publications and authorship of six books in these areas.
Professional Background and Experience
Manmohan Singh has held significant leadership positions across major pharmaceutical companies. At Takeda Pharmaceuticals, he served as the Global Head of Drug Product Development for vaccine programs, including overseeing Takeda's dengue vaccine in Phase III efficacy study. His prior role at Novartis as Head of Formulation Development was pivotal for over 10 years, where he contributed to the licensure of major vaccines like Bexsero, Fluad, and Flucelvax, which were later divested to GSK and CSL. Additionally, he led the development of the LNP platform for Novartis's RNA vaccine.
Achievements in Vaccine Development
Throughout his career, Manmohan Singh has been instrumental in advancing vaccine development. During his tenure at Chiron Corporation, he led the development of novel adjuvants and delivery systems. His leadership in this domain earned him recognition, such as being elected a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in 2011. His contributions to the field have been integral to achieving licensure for several key vaccines.
Publications and Thought Leadership
Manmohan Singh is a prolific author, with over 120 publications to his name. His thought leadership extends to six authored books focusing on adjuvants and vaccine delivery systems, establishing him as a thought leader in the pharmaceutical sciences. His work has influenced both academic research and practical applications in drug and vaccine development.